Awni M. Sarrif

1.0k total citations
31 papers, 854 citations indexed

About

Awni M. Sarrif is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Awni M. Sarrif has authored 31 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Awni M. Sarrif's work include Carcinogens and Genotoxicity Assessment (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and bioluminescence and chemiluminescence research (3 papers). Awni M. Sarrif is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and bioluminescence and chemiluminescence research (3 papers). Awni M. Sarrif collaborates with scholars based in United States, Lebanon and United Kingdom. Awni M. Sarrif's co-authors include Charles Heidelberger, Michael G. Brattain, Gerald L. Kennedy, John Durant, W. W. C. Read, W M Crist, Atsunobu Yoda, Michael E. Kamarck, John S. Bertram and Vincent L. Reynolds and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and JNCI Journal of the National Cancer Institute.

In The Last Decade

Awni M. Sarrif

30 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Awni M. Sarrif United States 17 324 184 158 140 120 31 854
Ayako Sakai Japan 21 660 2.0× 228 1.2× 417 2.6× 237 1.7× 120 1.0× 81 1.5k
Untae Kim United States 19 364 1.1× 308 1.7× 176 1.1× 38 0.3× 29 0.2× 39 1.2k
Jun Yatsunami Japan 19 519 1.6× 276 1.5× 161 1.0× 28 0.2× 164 1.4× 40 1.2k
I. Berenblum Israel 19 576 1.8× 232 1.3× 384 2.4× 105 0.8× 13 0.1× 75 1.3k
Chitra Thakur United States 18 633 2.0× 213 1.2× 282 1.8× 50 0.4× 84 0.7× 49 968
J.F. Lechner United States 10 466 1.4× 213 1.2× 209 1.3× 108 0.8× 13 0.1× 13 1.0k
Husam S. Younis United States 21 634 2.0× 125 0.7× 76 0.5× 278 2.0× 142 1.2× 36 1.4k
Caitlin Harris United States 10 485 1.5× 160 0.9× 363 2.3× 212 1.5× 15 0.1× 15 1.1k
M G McMenamin United States 6 424 1.3× 255 1.4× 176 1.1× 95 0.7× 13 0.1× 11 997
Marjorie Coggan Australia 23 2.3k 7.1× 175 1.0× 197 1.2× 91 0.7× 73 0.6× 50 2.9k

Countries citing papers authored by Awni M. Sarrif

Since Specialization
Citations

This map shows the geographic impact of Awni M. Sarrif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Awni M. Sarrif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Awni M. Sarrif more than expected).

Fields of papers citing papers by Awni M. Sarrif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Awni M. Sarrif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Awni M. Sarrif. The network helps show where Awni M. Sarrif may publish in the future.

Co-authorship network of co-authors of Awni M. Sarrif

This figure shows the co-authorship network connecting the top 25 collaborators of Awni M. Sarrif. A scholar is included among the top collaborators of Awni M. Sarrif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Awni M. Sarrif. Awni M. Sarrif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarrif, Awni M., et al.. (2006). Absorption, Distribution, and Excretion of Ammonium Perfluorooctanoate (APFO) After Oral Administration to Various Species. Drug and Chemical Toxicology. 29(2). 137–145. 122 indexed citations
2.
Sarrif, Awni M., et al.. (2006). Environmental genotoxins in children and adults: Concluding remarks. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 608(2). 169–170. 1 indexed citations
3.
Autrup, H, Riccardo Crebelli, L.M. Henderson, et al.. (2000). Thresholds in genetic toxicology — concluding remarks. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 464(1). 149–153. 20 indexed citations
4.
Sarrif, Awni M., et al.. (1994). Evalution of benomyl and carbendazim in the vivo aneuploidy/micronucleus assay in BDF1 mouse bone marrow. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 310(1). 143–149. 34 indexed citations
5.
Cunningham, Mary Jane, et al.. (1990). In vitro and in vivo genotoxicity of 1,3-butadiene and metabolites.. Environmental Health Perspectives. 86. 75–78. 23 indexed citations
6.
Brattain, Michael G., et al.. (1982). Enhancement of Growth of Human Colon Tumor Cell Lines by Feeder Layers of Murine Fibroblasts<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 69(4). 767–71. 24 indexed citations
7.
8.
Sarrif, Awni M., Hiroshi Tone, Peter V. Danenberg, & Charles Heidelberger. (1980). The Incorporation of Trifluorothymidine into Calf Thymus DNA in a Cell-Free System Does Not Lead to Chain Termination. Molecular Pharmacology. 18(1). 148–150. 1 indexed citations
9.
Sarrif, Awni M., et al.. (1980). Mutations and cell transformation with 2-azido-9-fluorenone oxime. In Vitro Cellular & Developmental Biology - Plant. 16(6). 541–546. 3 indexed citations
10.
Sarrif, Awni M., et al.. (1980). Inhibition of nucleoside phosphorylase cleavage of 5-fluoro-2'-deoxyuridine by 2,4- pyrimidinedione derivatives. Biochemical Pharmacology. 29(7). 1059–1063. 26 indexed citations
11.
Crist, W M, et al.. (1979). Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia. Blood. 54(5). 1164–1170. 62 indexed citations
12.
Monti, John A., et al.. (1979). Differential rotational mobility of a membrane-bound fluorochrome in cell types of increasing oncogenic potential. Archives of Biochemistry and Biophysics. 193(2). 496–501. 7 indexed citations
13.
Sarrif, Awni M., et al.. (1979). Establishment of photoaffinity label derivatives of fluorene as probes in studies of chemical carcinogenesis in mammalian cell culture.. PubMed. 39(10). 3903–8. 4 indexed citations
14.
Sarrif, Awni M., et al.. (1978). Photolysis of 2-Azidofluorene in situ as a probe in chemical carcinogenesis: Bypass of requirement for metabolic activation. Biochemical and Biophysical Research Communications. 83(2). 506–512. 9 indexed citations
15.
Sarrif, Awni M.. (1976). Hepatitis associated antigen. Incidence among blood donors and hospital staff in Jordan.. Jordan Medical Journal. 11(1). 7–12. 3 indexed citations
16.
Sarrif, Awni M., Peter V. Danenberg, Charles Heidelberger, & B Ketterer. (1976). Separate identities of ligandin and the h-protein, a major protein to which carcinogenic hydrocarbons are covalently bound. Biochemical and Biophysical Research Communications. 70(3). 869–877. 18 indexed citations
17.
Sarrif, Awni M., John S. Bertram, Michael E. Kamarck, & Charles Heidelberger. (1975). The isolation and characterization of polycyclic hydrocarbon-binding proteins from mouse liver and skin cytosols.. PubMed. 35(3). 816–24. 27 indexed citations
18.
Sarrif, Awni M., et al.. (1972). Analysis of Scopolamine and Its Degradation Products by GLC and Liquid Partition Chromatography. Journal of Pharmaceutical Sciences. 61(8). 1311–1313. 5 indexed citations
19.
Read, W. W. C. & Awni M. Sarrif. (1965). Human Milk Lipids. American Journal of Clinical Nutrition. 17(3). 177–179. 30 indexed citations
20.
Sarrif, Awni M., et al.. (1965). Influence of Vitamin A on Human Colostrum and Early Milk. American Journal of Clinical Nutrition. 17(3). 139–142. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayako Sakai Breakdown of academic impact, for papers by Untae Kim Breakdown of academic impact, for papers by Jun Yatsunami Breakdown of academic impact, for papers by I. Berenblum Breakdown of academic impact, for papers by Chitra Thakur Breakdown of academic impact, for papers by J.F. Lechner Breakdown of academic impact, for papers by Husam S. Younis Breakdown of academic impact, for papers by Caitlin Harris Breakdown of academic impact, for papers by M G McMenamin Breakdown of academic impact, for papers by Marjorie Coggan
Rankless by CCL
2026